Europe
Asia
Oceania
Americas
Africa
Both the pharmaceutical group’s key treatments have disappoint
WHO IS WINNING BETWEEN NOVO-NORDISK AND ELI LILLY?
It could take a long time to reverse decades of lagging behind the US
A whistle-stop tour of new faces, farewells, winners and losers
THE COMPANIES BOOSTING RETURNS TO SHAREHOLDERS
The wild west of weight-loss injections
Analysts suggest executive order was ‘all bark, little bite’
